Zynex Razão de venda descoberta
Qual é o Razão de venda descoberta de Zynex?
O Razão de venda descoberta de Zynex, Inc. é 14.45
Qual é a definição de Razão de venda descoberta?
Razão da venda descoberta é o número de acções vendidas a descoberto dividido pelo volume médio diário.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Razão de venda descoberta de empresas na Setor Health Care em TSXV em comparação com Zynex
O que Zynex faz?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Empresas com razão de venda descoberta semelhantes a Zynex
- Oculus VisionTech tem Razão de venda descoberta de 14.33
- Vintage Wine Estates tem Razão de venda descoberta de 14.39
- ServisFirst Bancshares Inc tem Razão de venda descoberta de 14.41
- eXp World tem Razão de venda descoberta de 14.42
- eXp World Inc tem Razão de venda descoberta de 14.42
- TPG Pace Tech Opportunities tem Razão de venda descoberta de 14.44
- Zynex tem Razão de venda descoberta de 14.45
- Enviva Inc tem Razão de venda descoberta de 14.46
- Contango Oil & Gas tem Razão de venda descoberta de 14.47
- Meed Growth Corp tem Razão de venda descoberta de 14.53
- Haverty Furniture Companies tem Razão de venda descoberta de 14.55
- Sangoma Technologies Corporatio tem Razão de venda descoberta de 14.57
- Bellicum Pharmaceuticals Inc tem Razão de venda descoberta de 14.70